Search

Author/Creator Ciceri, F

2. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Issue 8 (12th July 2004)

Authors:
Farge, D; Passweg, J; van Laar, J M; Marjanovic, Z; Besenthal, C; Finke, J; Peter, H H; Breedveld, F C; Fibbe, W E; Black, C; Denton, C; Koetter, I; Locatelli, F; Martini, A; Schattenberg, A V N; van den Hoogen, F; van de Putte, L; Lanza, F; Arnold, R; Bacon, P A
Journal:
Annals of the rheumatic diseases
Issue:
Volume 63:Issue 8(2004)
Page Start:
974
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide. (December 2018)

Authors:
Mussetti, A; Philippis, C; Carniti, C; Bastos-Oreiro, M; Gayoso, J; Cieri, N; Pennisi, M; Ciceri, F; Greco, R; Peccatori, J; Patriarca, F; Mariotti, J; Castagna, L; Corradini, P
Journal:
Bone marrow transplantation
Issue:
Volume 53:Number 12(2018)
Page Start:
1522
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. OS05.6.A Modification of the tumor microenvironment in patients with glioblastoma using autologous, genetically modified, hematopoietic stem cell-based therapy: the TEM-GBM STUDY (NCT03866109). (5th September 2022)

Authors:
Finocchiaro, G; Eoli, M; Gentner, B; Bruzzone, M; Di Meco, F; Mortini, P; Olivi, A; Naldini, L; Russo, C; Ciceri, F
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 2
Page Start:
ii13
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P05.02 A phase I/IIa dose escalation study evaluating the safety and efficacy of autologous CD34+ enriched hematopoietic progenitor cells genetically modified for human interferon-α2 in patients with GBM and an unmethylated MGMT promoter (TEM-GBM-001). (6th September 2019)

Authors:
Gentner, B; Ciceri, F; DiMeco, F; Legnani, F; Eoli, M; Pollo, B; Farina, F; Mazzoleni, S; Russo, C; Naldini, L; Finocchiaro, G
Journal:
Neuro-oncology
Issue:
Volume 21(2019)Supplement 3
Page Start:
iii34
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. S106: LONG-TERM FOLLOW-UP OF BETA-THALASSEMIA PATIENTS TREATED WITH HEMATOPOIETIC STEM CELL GENE THERAPY. (31st January 2022)

Authors:
Marktel, S; Scaramuzza, S; Giglio, F; Cicalese, M; Lidonnici, M; Rossi, C; Calbi, V; Masera, N; D'Angelo, E; Mirra, N; Origa, R; Tartaglione, I; Perrotta, S; Viarengo, G; Santoleri, L; Milani, R; Gattillo, S; Calabria, A; Montini, E; Graziadei, G
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 1
Page Start:
3
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗